Breaking the odds: A rare case of bilateral breast angiosarcoma
Keywords:
Breast Angiosarcoma, Breast MRI, Radiation Therapy, Soft tissues, Breast Oncology, Diagnostic ChallengesAbstract
Breast angiosarcoma is an extremely rare and aggressive tumor, presenting several challenges in diagnosis and treatment. Imaging techniques play a crucial role in the early diagnostic assessment, initially allowing for a differential diagnosis with other breast tumors (using ultrasound and MRI techniques) and subsequently for patient follow-up through CT and MRI examinations.
Currently, there is no standardized or unified treatment protocol, especially regarding metastatic forms, where the use of chemotherapy or radiotherapy remains subject of debate.
The rarity of this tumor entity suggests the need for future research and multidisciplinary collaboration in order to further optimize diagnostic accuracy and treatment options.
References
1. An R, Men XJ, Ni XH, Wang WT, Wang CL. Angiosarcoma of the breast: a review. Heliyon. 2024;10(3):e24413. doi: 10.1016/j.heliyon.2024.e24413
2. Ooe Y, Terakawa H, Kawashima H, Ikeda H, Inaki N. Bilateral primary angiosarcoma of the breast: a case report. J Med Case Rep. 2023;17:60. doi: 10.1186/s13256-023-03791-7
3. Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020;26(2):181-187. doi: 10.1038/s41591-019-0749-z
4. Wu WH, Ji QL, Li ZZ, Wang QN, Liu SY, Yu JF. Mammography and MRI manifestations of breast angiosarcoma. BMC Womens Health. 2019;19:73. doi: 10.1186/s12905-019-0769-3
5. Gao Y, Slanetz PJ, Eisenberg RL. Echogenic breast masses at US: to biopsy or not to biopsy? Radiographics. 2013;33(2):419-434. doi: 10.1148/rg.332125048
6. Conti M, Morciano F, Rossati C, et al. Angiosarcoma of the breast: overview of current data and multimodal imaging findings. J Imaging. 2023;9(5):94. doi: 10.3390/jimaging9050094
7. Sanders LM, Groves AC, Schaefer S. Cutaneous angiosarcoma of the breast on MRI. AJR Am J Roentgenol. 2006;187(2):143-146. doi: 10.2214/AJR.05.1940
8. Stacchiotti S, Palassini E, Sanfilippo R, et al. Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol. 2012;23(2):501-508. doi: 10.1093/annonc/mdr066
9. Lewcun JA, Pameijer C, Kass R, et al. Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: two case reports. Int J Surg Case Rep. 2020;68:83-87. doi: 10.1016/j.ijscr.2020.02.036
10. Zhu Y, Nakamoto S, Tsukioki T, et al. Primary angiosarcoma of the breast: a literature review. Chin Clin Oncol. 2024;13(5):68. doi: 10.21037/cco-24-16
11. Depla AL, Scharloo-Karels CH, de Jong MAA, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779-1788. doi: 10.1016/j.ejca.2014.03.002
12. Palta M, Morris CG, Grobmyer SR, Copeland EM 3rd, Mendenhall NP. Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer. 2010;116(8):1872-1878. doi: 10.1002/cncr.24995
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sara Maria Pizzileo , Francesco Pizzolorusso, Angelo Errico, Giulia Iacobellis, Annalisa Lamacchia, Stefano De Lorenzis, Santa Bambace, Giuseppe Guglielmi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.